Publications by authors named "Anna Filonenko"

Claim this Profile
V
Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies.
Claudia Haberland, Anna Filonenko, Christian Seitz, Matthias Börner, Christoph Gerlinger

J Patient Rep Outcomes· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of bronchiectasis - known and unknown: a systematic review.
Pieter C Goeminne, Francisco Hernandez, Roland Diel, Anna Filonenko, Rowena Hughes

BMC Pulm Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross design analysis of randomized and observational data - application to continuation rates for a contraceptive intra uterine device containing Levonorgestrel in adolescents and adults.
Tatsiana Vaitsiakhovich, Anna Filonenko, Richard Lynen, Jan Endrikat, Christoph Gerlinger

BMC Womens Health· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.
James D Chalmers, Stefano Aliberti, Anna Filonenko, Michal Shteinberg, Pieter C Goeminne

Am J Respir Crit Care Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct costs of unintended pregnancy in Spain.
Iñaki Lete, Fareen Hassan, Ismini Chatzitheofilou, Eifiona Wood, Joan Mendivil, Anna Filonenko

Eur J Contracept Reprod Health Care· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives.
Amanda Y Black, Edith Guilbert, Fareen Hassan, Ismini Chatziheofilou, Julia Lowin, Anna Filonenko

J Obstet Gynaecol Can· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.
Nathaniel Henry, Charlie Hawes, Julia Lowin, Ingrid Lekander, Anna Filonenko

Acta Obstet Gynecol Scand· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception.
Nathaniel Henry, Max Schlueter, Julia Lowin, Ingrid Lekander, Anna Filonenko

J Fam Plann Reprod Health Care· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct costs of unintended pregnancy in the Russian federation.
Julia Lowin, James Jarrett, Maria Dimova, Victoria Ignateva, Vitaly Omelyanovsky, Anna Filonenko

Appl Health Econ Health Policy· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network.
Lucía Cea Soriano, Mari-Ann Wallander, Susan Andersson, Anna Filonenko, Luis Alberto García Rodríguez

Pharmacoepidemiol Drug Saf· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving cost-neutrality with long-acting reversible contraceptive methods.
James Trussell, Fareen Hassan, Julia Lowin, Amy Law, Anna Filonenko

Contraception· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of long-acting reversible contraceptives in the UK from 2004 to 2010: analysis using The Health Improvement Network Database.
Lucía Cea Soriano, Mari-Ann Wallander, Susan Andersson, Anna Filonenko, Luis Alberto García Rodríguez

Eur J Contracept Reprod Health Care· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.
James Trussell, Fareen Hassan, Nathaniel Henry, Jennifer Pocoski, Amy Law, Anna Filonenko

Contraception· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EVAPIL-R Scale: Continuous development and validation of a tool to assess patient-reported tolerability of different contraceptive methods in longitudinal studies.
Pierre Clerson, Olivier Graesslin, Adam Gater, Fiona Taylor, Anna Filonenko

Clin Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding.
David C Hoaglin, Anna Filonenko, Mark E Glickman, Radek Wasiak, Risha Gidwani

Eur J Med Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
Michael L Ganz, Dhvani Shah, Risha Gidwani, Anna Filonenko, Wenqing Su

Value Health· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
Radoslaw Wasiak, Anna Filonenko, David J Vanness, Amy Law, Mark Jeddi

J Womens Health (Larchmt)· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception.
James Trussell, Nathaniel Henry, Fareen Hassan, Alexander Prezioso, Amy Law, Anna Filonenko

Contraception· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding.
Radoslaw Wasiak, Anna Filonenko, David J Vanness, Kim U Wittrup-Jensen, Donald E Stull

Int J Womens Health· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities.
Lothar A J Heinemann, Thai Do Minh, Klaas Heinemann, Marion Lindemann, Anna Filonenko

Health Care Women Int· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment satisfaction instruments for different purposes during a product's lifecycle: keeping the end in mind.
Diana Rofail, Fiona Taylor, Antoine Regnault, Anna Filonenko

Patient· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life.
Lothar A J Heinemann, Thai Do Minh, Anna Filonenko, Kerstin Uhl-Hochgräber

Patient· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity.
Lothar A J Heinemann, Thai Do Minh, Anna Filonenko, Kerstin Uhl-Hochgräber

Womens Health Issues· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis